Trial Profile
A Phase 1, Open-Label Study to Evaluate Single Dose Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone (MNTX) in Subjects With Impaired Renal Function
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 May 2019
Price :
$35
*
At a glance
- Drugs Methylnaltrexone bromide (Primary)
- Indications Constipation
- Focus Pharmacokinetics
- Sponsors Progenics Pharmaceuticals
- 17 Jul 2011 Salix Pharmaceuticals added as company as reported by ClinicalTrials.gov.
- 10 Jun 2011 New trial record